Literature DB >> 3008176

Pathology of germ cell tumors of testes.

F K Mostofi, I A Sesterhenn.   

Abstract

We have presented a brief discussion of WHO International Histological Classification of Testicular Germ Cell Tumors. This classification divides the tumors into those of one histologic type and those of more than one type. Seven basic histological categories are recognized: seminoma, spermatocytic seminoma, embryonal carcinoma, yolk sac tumor, polyembryoma, choriocarcinoma and teratoma. Comparison of the WHO classification with the Pugh-Cameron classification reveals that except for seminoma and spermatocytic seminoma comparability between the 2 classifications is impossible. The relationship of various cell types to each other has been discussed. The origin of each cell type from malignant transformation of germ cell has been emphasized. The WHO classification has been demonstrated to correlate well with clinical tumor markers. The Pugh-Cameron classification can not be correlated with markers. More importantly, by specifying the individual components that are present in a tumor, the WHO classification provides exact information as to the possible structure of metastasis so that the urologist is in a much better position to properly manage the patient with a metastatic testicular tumor.

Entities:  

Mesh:

Year:  1985        PMID: 3008176

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  10 in total

Review 1.  Human spermatogonial stem cells: a possible origin for spermatocytic seminoma.

Authors:  R Waheeb; M-C Hofmann
Journal:  Int J Androl       Date:  2011-08

2.  NANOG promoter methylation and expression correlation during normal and malignant human germ cell development.

Authors:  Daniel Nettersheim; Katharina Biermann; Ad J M Gillis; Klaus Steger; Leendert H J Looijenga; Hubert Schorle
Journal:  Epigenetics       Date:  2011-01-01       Impact factor: 4.528

Review 3.  [Testicular seminomas. The classical and the less classical ones].

Authors:  P K Bode; H Moch
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

4.  Mixed germ cell tumor of the testicle with ravdomuosarcomatous component: a case report.

Authors:  Konstantinos Stamatiou; Panagiotis Papadopoulos; Georgios Perlepes; Nikolaos Galariotis; Michalis Olympitis; Hippocrates Moschouris; Theodora Vasilakaki
Journal:  Cases J       Date:  2009-12-10

Review 5.  New insights into the pathology and molecular biology of human germ cell tumors.

Authors:  Friedemann Honecker; J Wolter Oosterhuis; Frank Mayer; Jörg Thomas Hartmann; Carsten Bokemeyer; Leendert H J Looijenga
Journal:  World J Urol       Date:  2004-03-20       Impact factor: 4.226

6.  Mixed Germ Cell Tumour in an Infertile Male Having Unilateral Cryptorchidism: A Rare Case Report.

Authors:  Anand Singla; Navneet Kaur; Gunjeet Sandhu; Rupesh Nagori
Journal:  J Clin Diagn Res       Date:  2016-02-01

7.  The differentiation status of primary gonadal germ cell tumors correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase.

Authors:  Mark Schrader; Angelika M Burger; Markus Müller; Hans Krause; Bernd Straub; Martin Schostak; Wolfgang Schulze; Heidrun Lauke; Kurt Miller
Journal:  BMC Cancer       Date:  2002-11-29       Impact factor: 4.430

8.  Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors.

Authors:  Dennis M Timmerman; Thomas F Eleveld; Sruthi Sriram; Lambert C J Dorssers; Ad J M Gillis; Silvia Schmidtova; Katarina Kalavska; Harmen J G van de Werken; Christoph Oing; Friedemann Honecker; Michal Mego; Leendert H J Looijenga
Journal:  J Clin Oncol       Date:  2022-04-20       Impact factor: 50.717

9.  Comparative immunohistochemical characterization of canine seminomas and Sertoli cell tumors.

Authors:  Chi-Ho Yu; Du-Na Hwang; Ji-Young Yhee; Jong-Hyuk Kim; Keum-Soon Im; Whan-Gook Nho; Young-Soo Lyoo; Jung-Hyang Sur
Journal:  J Vet Sci       Date:  2009-03       Impact factor: 1.672

10.  CMTM3 inhibits human testicular cancer cell growth through inducing cell-cycle arrest and apoptosis.

Authors:  Zesong Li; Jun Xie; Jianting Wu; Wenjie Li; Liping Nie; Xiaojuan Sun; Aifa Tang; Xianxin Li; Ren Liu; Hongbing Mei; Feng Wang; Zhiping Wang; Yaoting Gui; Zhiming Cai
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.